A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Healthy
Interventions
DRUG

Sandimmune® Injection

DRUG

NeuroSTAT®

Trial Locations (1)

9301

PAREXEL, Bloemfontein

Sponsors
All Listed Sponsors
lead

NeuroVive Pharmaceutical AB

INDUSTRY